New Perspectives in the Diagnosis and Management of Insomnia (59 Minutes)

Faculty: David Neubauer, MD, Milton K. Erman, MD, and Phyllis Zee, MD, PhD

This CME Expert Review PsychCast™ is jointly sponsored by the Mount Sinai School of Medicine and MBL Communications.

Release Date: January 2009
Termination Date: January 31, 2011

Estimated time to complete this activity: 1 hour

Medium: The content is delivered by PsychCast™ with a PDF or web-based Posttest

Acknowledgment of Commercial Support: Funding for this activity has been provided by an educational grant from sanofi-aventis.

CME Course Director: This activity has been peer reviewed and approved by James C.-Y. Chou, MD, associate professor of psychiatry at the Mount Sinai School of Medicine. Review Date: Nov. 25, 2008.

Faculty Affiliation

Dr. Neubauer is assistant professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins Medical School in Baltimore, Maryland, and is associate director of the Johns Hopkins Sleep Disorders Center.

Dr. Erman is a voluntary clinical professor in the Department of Psychiatry at the School of Medicine of the University of California, San Diego, and is chief medical officer at Avastra, USA. He is also staff scientist in the Department of Neuropharmacology at the Scripps Research Institute, La Jolla, California.

Dr. Zee is professor of Neurology and Neurobiology and Physiology, and is director of the Sleep Disorders Center at Northwestern University in Evanston, Illinois.

Faculty Disclosure Policy Statement
It is the policy of the Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Faculty Disclosure
Dr. Neubauer serves as a consultant or advisor to sanofi-aventis and Takeda, and receives honoraria from sanofi-aventis and Takeda. He discusses the unapproved use of antidepressants for the treatment of insomnia.

Dr. Erman serves on the advisory board of sanofi-aventis and Takeda; serves as a consultant for Actelion, sanofi-aventis, and Takeda; receives research support from Actelion, Arena, Cephalon, Eli Lilly, GlaxoSmithKline, Medicinova, Merck, Organon, Pfizer, sanofi-aventis, Schwarz Pharma, Takeda, Transcept, Vanda, and Wyeth; serves on the speakers bureaus at Cephalon, sanofi-aventis, and Takeda; and owns stock in Cephalon, Forest, Neurocrine, Pfizer, Sepracor, sanofi-aventis, and Somaxon.

Dr. Zee serves as a consultant or advisor to GlaxoSmithKline, sanofi-aventis and Takeda, receives research support from Takeda, receives compensation for service on an advisory board from Jazz and sanofi-aventis, and receives royalty payments from Lippincott and Wilkins.

Dr. Chou has received honoraria from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, and Pfizer.

Learning Objectives

At the completion of this activity, participants should be better able to:

• Prioritize patients at risk for insomnia, including those with comorbid mood disorders, women, and the elderly
  
• Summarize recent data related to the impact of sleep on medical and psychiatric health and use this knowledge in the assessment and treatment of patients with insomnia
  
• Apply treatment strategies to improve patient outcomes in insomnia and limit chronicity

Target Audience: This activity is designed to meet the educational needs of primary care physicians and psychiatrists.

Accreditation Statement: This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Mount Sinai School of Medicine and MBL Communications, Inc. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: The Mount Sinai School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclaimer: These are the opinions of the authors not of the sponsors or supporters. For more information, contact MBL Communications at cme@mblcommunications.com.

Minimum Hardware/Software Requirements

Macintosh: PowerPC processor, Mac OS 8.6, 9.0.4, 9.1, or Mac OS X, 64MB of RAM, 24MB of available hard-disk space, and Safari 1.x or 2.x.
Windows PC: Intel Pentium processor, Microsoft Windows 95 OSR 2.0, Windows 98 and 98 SE, Windows Millennium Edition, Windows NT 4.0 with Service Pack 5, Windows 2000, or Windows XP, 64MB of RAM, 24MB of available hard-disk space, and Internet Explorer 6.x and newer or Firefox 1.x and newer.

This CME Activity and Posttest information file is a PDF (Portable Document Format) document. To view this file, you will need Adobe Acrobat Reader, which is available free at www.adobe.com. Follow the instructions on that page to download and install the software.